Dendritic-cell-based therapeutic vaccina
โ
Frank O Nestle; Arpad Farkas; Curdin Conrad
๐
Article
๐
2005
๐
Elsevier Science
๐
English
โ 133 KB
Early clinical trials, in which over 1000 cancer patients received dendritic cell (DC) vaccines, tested different vaccine preparations, but they did not always induce sufficient acquired immunity or meet the expected level of tumor regressions. Current studies aim to improve the DC vaccine approach